EXTH-23. MULTIVALENT TARGETED CYTOLYTIC AGENTS FOR GLIOBLASTOMA TREATMENT

Glioblastoma (GBM) complexity and heterogeneity requires treatment that addresses those pathobiological features. We have been developing selective cytotoxic agents able to target at the same time several GBM-associated factors. The chosen targets are responsible for the disease progression and/or r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Sharma, Puja, Herpai, Denise, Roberts, Callie, Fokt, Izabela, Priebe, Waldemar, Tatter, Stephen, Rossmeisl, John, Debinski, Waldemar
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Preclinical Experimental Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651650/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.377
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki